...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Circulation journal >Management of Patients With Aortic Stenosis Requiring Non-Cardiac Surgery
【24h】

Management of Patients With Aortic Stenosis Requiring Non-Cardiac Surgery

机译：具有非心脏手术的主动脉狭窄患者的管理

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

0n this issue of the Journal, Taniguchi et al report thatsevere, untreated, symptomatic or asymptomatic aorticstenosis (AS) is likely to be associated with a higherrisk of perioperative death following major non-cardiacsurgery.1 In their study, 4.3% of patients with severe ASwho did not undergo prior aortic valve replacement (AVR)died following elective non-cardiac surgery, whereas noneof the patients who underwent AVR before non-cardiacsurgery died. Of note, none of the severe AS patients diedfollowing low-risk non-cardiac surgery (i.e., superficialsurgery), even without AVR. Their study exclusivelyincluded severe AS patients and did not include patientswith mild or moderate AS. Despite the limitations of the retrospective study design without risk adjustment, thestudy provides a clear message to clinicians: patients withsevere AS, even if asymptomatic, might benefit from prioraortic valve intervention (surgical AVR (SAVR) or transcatheterAVR (TAVR)) before undergoing major noncardiacsurgery.
机译：0N这个问题的期刊，Taniguchi等人报告说，未经治疗的，症状或无症状的主动脉杆菌（AS）可能与主要的非心肺手术中的围手术期高，4.3％的严重患者有关由于在选修的非心脏病外，aswho未接受主动脉瓣置换（avr），而在非心肺术前患有AVR的患者中，患者均未死亡。注意，即使没有AVR，患者也没有严重的患者患者患者患有低风险的非心脏手术（即，卓越性的锻造）。他们的学习仅仅是患者严重的，并且不包括患者温和或中等的患者。尽管回顾性研究设计的局限性没有风险调整，但Thestudy为临床医生提供了明确的信息：患者在接受主要的非心囊之前，患者也可能受益于PrainToric Valst vall intervent（手术AVR（Savr）或经触发表（Tavr））之前受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号